UBS Group AG - NUVATION BIO INC ownership

NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 121 filers reported holding NUVATION BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NUVATION BIO INC
ValueSharesWeighting
Q3 2023$128,112
-25.3%
95,606
+0.3%
0.00%
Q2 2023$171,578
-6.3%
95,321
-13.6%
0.00%
Q1 2023$183,188
+1309.1%
110,354
+1863.6%
0.00%
Q3 2022$13,000
+62.5%
5,620
+116.5%
0.00%
Q2 2022$8,0002,596
+7111.1%
0.00%
Q1 2022$0
-100.0%
36
-92.9%
0.00%
Q4 2021$4,000
+300.0%
509
+485.1%
0.00%
Q3 2021$1,0000.0%87
+29.9%
0.00%
Q2 2021$1,000
-95.5%
67
-96.8%
0.00%
Q1 2021$22,0002,0630.00%
Other shareholders
NUVATION BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 22,957,340$120,756,00024.71%
Aisling Capital Management LP 2,541,009$13,366,0007.21%
EDBI Pte Ltd 1,270,504$6,683,0004.45%
Ally Bridge Group (NY) LLC 1,137,152$5,981,0004.43%
EcoR1 Capital, LLC 13,896,543$73,096,0002.29%
Boxer Capital, LLC 4,341,009$22,834,0001.17%
Baupost Group 10,443,494$54,933,0000.59%
Redmile Group, LLC 3,471,709$18,261,0000.57%
Avidity Partners Management LP 4,855,006$25,537,0000.53%
Abrams Capital Management 3,811,513$20,049,0000.47%
View complete list of NUVATION BIO INC shareholders